Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|October 31, 2022
Targeting CD38 for acute leukemiaXushu Zhong, Hongbing Ma
The Tohoku Journal of Experimental Medicine|April 15, 2016
Diabetes Insipidus as an Initial Presentation of Myelodysplastic Syndrome: Diagnosis with Single-Nucleotide Polymorphism Array-Based KaryotypingRuixue Sun, Chun Wang, Xushu Zhong, et al.
Hematology (Amsterdam, Netherlands)|February 3, 2025
Sintilimab for treating progressive multifocal leukoencephalopathy caused by human polyomavirus 2 virus infection following allogeneic hematopoietic cell transplantation: a case reportXuelian Jin, Xushu Zhong, Qinyu Liu, et al.
Frontiers in Immunology|June 15, 2026
Case Report: Hemophagocytic lymphohistiocytosis masquerading as drug-induced liver injury: successful treatment with low-dose ruxolitinib and glucocorticoidsYang Dai, Luocheng Zhang, Xushu Zhong, et al.
Frontiers in Immunology|June 22, 2026
Case Report: A diagnostic chameleon of EBV-associated immune dysregulation: HLH unmasking multiple myeloma with subsequent emergence of aggressive B-cell lymphomaYang Dai, Luocheng Zhang, Xushu Zhong, et al.
Frontiers in Oncology|June 29, 2026
Case Report: Ultrasound-guided percutaneous splenic biopsy as a lifesaving diagnostic modality in B-cell lymphoma presenting as hemophagocytic lymphohistiocytosis: a report of two casesZhuohang Zou, Yang Dai, Xushu Zhong, et al.
Hematology (Amsterdam, Netherlands)|November 25, 2024
Combining azole antifungals with venetoclax plus azacitidine in patients with newly diagnosed acute myeloid leukemiaXushu Zhong, Jia Wang, Yang Dai, et al.
Biochemical Pharmacology|April 19, 2026
Pharmacologic modulation of the SAT1-N1-acetylspermidine axis is associated with enhanced chemotherapy cytotoxicity in T-LBL/ALL cellsQinyu Liu, Wen Zheng, Yunfan Yang, et al.
Frontiers in Oncology|November 17, 2025
Identification and prognostic prediction of high-risk multiple myeloma by exosomal microRNAYing Tian, Wenjiao Tang, Chunlan Zhang, et al.
British Journal of Haematology|August 30, 2023
Angioimmunoblastic T-cell lymphoma: Novel recurrent mutations and prognostic biomarkers by cell-free DNA profilingChunlan Zhang, Biqin Mou, Juan Xu, et al.
Pageof 2